The rather vanilla phrase “creative differences” is often used whenever a major component of a movie production exits the project abruptly. An explanation offered up as much to prevent the embarrassment of the exiting talent as it is to hide any production problems from studio shareholders, the phrase disguises or glosses over the often-bitter disagreements that creative types have with the studio executives funding their projects. It can have a devastating impact on the exiting writer or director’s career, but it doesn’t necessarily spell doom for the movie itself.
Eon Productions, the production company owned by the Broccoli family that have made all of the James Bond films, has parted ways with Dan Romer, the composer of the latest 007 movie, No Time to Die, just a few months shy of the movie’s release citing “creative differences.” Stepping in to complete the score is Academy Award-winning composer Hans Zimmer, who has apparently already been working on the score for some time. The news was first revealed by director Cary Fukunaga (HBO’s True Detective) in a Facebook post.
No Time to Die opens in theaters on April 10th.
Even at such a late stage, it’s hard to imagine the addition of 11-time Academy Award-nominee Hans Zimmer to the No Time to Die production is anything but a good thing, but the loss of visionary director Scott Derrickson from the Doctor Strange in the Multiverse of Madness production just four months before filming is set to begin is troublesome. Doctor Strange was never one of the more popular Marvel Comics character and was little known in popular culture, but Derrickson managed to introduce the character — and magic! — into the MCU as the co-writer and director of the first Doctor Strange in a mind-bending and visually-stunning movie that threaded the needle between superhero fiction and fantasy.
Derrickson promised to bring horror into the MCU in the sequel with the classic villain Nightmare rumored to be a major player. Now, it is feared, that his attempts to push the envelope of what a PG-13 Marvel movie could be have been quashed by Marvel overlord Kevin Feige as Derrickson was unceremoniously dumped due to “creative differences,” this time with a tweet from Derrickson himself that basically echoed Marvel’s statement without offering any details. He will remain on as an executive producer, but the title may only be ceremonial. A search is underway for his replacement.
Marvel and I have mutually agreed to part ways on Doctor Strange: In the Multiverse of Madness due to creative differences. I am thankful for our collaboration and will remain on as EP.
— N O S ⋊ Ɔ I ᴚ ᴚ Ǝ ᗡ ⊥ ⊥ O Ɔ S (@scottderrickson) January 10, 2020
Doctor Strange in the Multiverse of Madness is slated to open in theaters on May 7, 2021.
Images courtesy of Eon Productions/MGM & Disney/Marvel Studios; Edits by Movie Nooz